<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="patients. While effective COVID-19 management requires both antiviral and anti-inflammatory" exact="treatment" post="strategies, the need forÂ a potent and safe antiviral"/>
 <result pre="approval of remdesivir, a nucleoside analog originally developed for the" exact="treatment" post="Ebola virus infections, has added hopeÂ to the early"/>
 <result pre="the human kinome to identify host kinases relevant for SARS-CoV" exact="infection" post="[22]. Their work alsoÂ showed other proteins that promote"/>
 <result pre="acute infections that can resolve within a few weeks. Therefore," exact="treatment" post="strategies are characterized by short term use, permitting a"/>
 <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitroCell Discov202061610.1038/s41421-020-0156-032194981 5.GaoJYangXBreakthrough: chloroquine phosphate has shown apparent"/>
 <result pre="vitroCell Discov202061610.1038/s41421-020-0156-032194981 5.GaoJYangXBreakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBiosci Trends202014727310.5582/bst.2020.0104732074550 6.GelerisJet"/>
 <result pre="hospitalized patients with Covid-19N Engl J Med202010.1056/NEJMoa201241032379955 7.RosenbergESet al.Association of" exact="treatment" post="with hydroxychloroquine or azithromycin with in-hospital mortality in patients"/>
 <result pre="of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients" exact="testing" post="positive for coronavirus disease 2019 (COVID-19)JAMA Cardiol201910.1001/jamacardio.2020.1834 9.SalehMet al.The"/>
</results>
